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Abstract
Hepcidin is an antimicrobial peptide, which also negatively regulates iron in circulation by controlling iron absorption from
dietary sources and iron release from macrophages. Hepcidin is synthesized mainly in the liver, where hepcidin is regulated
by iron loading, inflammation and hypoxia. Recently, we have demonstrated that bone morphogenetic protein (BMP)-
hemojuvelin (HJV)-SMAD signaling is central for hepcidin regulation in hepatocytes. Hepcidin is also expressed by
macrophages. Studies have shown that hepcidin expression by macrophages increases following bacterial infection, and
that hepcidin decreases iron release from macrophages in an autocrine and/or paracrine manner. Although previous studies
have shown that lipopolysaccharide (LPS) can induce hepcidin expression in macrophages, whether hepcidin is also
regulated by BMPs in macrophages is still unknown. Therefore, we examined the effects of BMP signaling on hepcidin
expression in RAW 264.7 and J774 macrophage cell lines, and in primary peritoneal macrophages. We found that BMP4 or
BMP6 alone did not have any effect on hepcidin expression in macrophages although they stimulated Smad1/5/8
phosphorylation and Id1 expression. In the presence of LPS, however, BMP4 and BMP6 were able to stimulate hepcidin
expression in macrophages, and this stimulation was abolished by the NF-kB inhibitor Ro1069920. These results suggest
that hepcidin expression is regulated differently in macrophages than in hepatocytes, and that BMPs regulate hepcidin
expression in macrophages in a LPS-NF-kB dependent manner.
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Introduction
Hepcidin, a small cationic peptide, was first identified based on
its antimicrobial and antifungal properties [1]; [2];[3]. Hepcidin
provides a first line of defense at mucosal barriers, although it is
not as potent as many other antimicrobial peptides [1]; [2];[3].
Recent studies demonstrated that hepcidin also acts as a major
hormone to regulate iron homeostasis. Hepcidin negatively
regulates iron in circulation by inhibiting iron absorption from
the duodenum, iron recyling from the monocyte/macrophage
system, and iron mobilization from hepatic stores. Hepcidin blocks
iron efflux by binding to the sole iron exporter ferroportin and
inducing its internalization and degradation. Hepcidin expression
is dramatically increased during infection and inflammation. This
leads to a marked decrease in serum iron, thus depriving microbes
of iron and decreasing their rate of growth [3].
Hepcidin is mainly synthesized by the liver. The expression of
hepcidin in hepatocytes increases in response to infection/
inflammation and elevated systemic iron. In isolated primary
hepatocytes, hepcidin expression is stimulated by IL-6, IL-1 and
lipopolysaccharide (LPS), but not by TNF-a [4]; [5]; [6]. Recently,
we and others discovered that bone morphogenetic protein (BMP)
signaling pathway is critically involved in regulating hepcidin
expression in the liver [7]; [8]; [9]; [10]; [11]. BMPs signal through
type II and type I serine threonine kinase receptors, which
phosphorylate intracellular receptor-activated Smad proteins
(Smad1/5/8). Phosphorylated Smad1/5/8 then bind to the
common mediator Smad4, and the Smad complex translocates
to the nucleus to regulate transcription of target genes such as Id1
[12]; [13]. BMP2, 4, 5, 6, and 9 have been shown to induce
hepcidin expression in isolated murine primary hepatocytes or in
hepatoma cell lines [14]; [9]; [10]. Administration of BMP2 or
BMP6 increases hepcidin expression and decreases serum iron
levels in mice [9]; [11]. Conversely, inhibition of BMP signaling
through genetic deletion of the ligand BMP6 [11]; [15], the BMP
type I receptor ALK3 [16], the BMP co-receptor hemojuvelin
(Hjv) [7], or Smad4 [8], or through administration of BMP ligand
antagonists HJV.Fc [9] or ALK3-Fc, or the BMP type I receptor
inhibitor LDN-193189 [16], results in low hepcidin expression in
the liver in mice. Thus, BMP signaling is an important regulatory
pathway for hepcidin expression in hepatocytes.
Hepcidin is also expressed by myeloid cells including mono-
cytes, macrophages and neutrophils [17]; [18]; [19]; [20]; [21];
PLOS ONE | www.plosone.org 1 September 2012 | Volume 7 | Issue 9 | e44622[22]; [23]. In contrast to hepatocytes, hepcidin expression in
macrophages is not induced by iron loading in mice [17].
Interestingly, expression of hepcidin in myeloid cells is increased
under stimulation of bacterial pathogens and LPS, and this
stimulation is dependent on TLR4 and NF-kB activities [18]; [22];
[23]. The autocrine and paracrine effects of hepcidin secreted by
monocytic lineages is to decrease iron efflux and promote iron
retention in these cells [19]; [21]. In fact, hepcidin-mediated iron
loading in macrophages and monocytes appears to increase their
inflammatory potential both in vitro and in vivo [24], consistent with
its other functions in promoting host defense. Considering 90–
95% of the serum iron comes from recycling of iron from damaged
erythrocytes by macrophages, the autocrine/paracrine action of
hepcidin in macrophages may be an important mechanism in
innate immune defense by which the host reduces the availability
of iron from pathogens, while simultaneously augmenting the
activity of innate immune effector cells.
Based on the pivotal role of BMP signaling in hepcidin
regulation in hepatocytes, we investigated whether or not BMP
signaling regulates hepcidin expression in macrophages. Surpris-
ingly, we found that macrophages did not increase hepcidin
expression in response to BMP stimulation, unless BMP signaling
was accompanied by co-stimulation with LPS.
Materials and Methods
Chemical and biochemical reagents
BMP4 and BMP6 were purchased from R & D Systems
(Minneapolis, MN). Lipopolysaccharides (LPS) from Escherichia
coli 0127:B8 was purchased from Sigma-Aldrich (Saint Louis,
MO). Phospho-Smad1/5/8, Smad1, phospho-NF-kB p65 and
NF-kB p65 antibodies were purchased from Cell Signaling
Technology (Beverly, MA). b-actin antibodies were purchased
from Sigma-Aldrich. NF-kB inhibitor Ro1069920 was purchased
from Santa Cruz Biotechnology, Inc (Santa Cruz, CA).
Cell Culture
RAW264.7 and J774 macrophage cell lines (ATCC) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% heat-inactivated fetal bovine serum
(Invitrogen), 2 mM L-glutamine, and antibiotics. Cells were
starved with serum-free DMEM supplemented with 0.1% bovine
serum albumin before they were incubated with BMP4, BMP6,
LPS or a combination of BMP ligands and LPS as indicated. Cells
were lysed for real-time PCR quantification of mRNA transcripts
or for Western blotting analyses for phosporylated Smad1/5/8
and phosphorylated NF-kB p65 levels.
Mature resident peritoneal macrophage were harvested and
cultured as previously described [25]. Briefly, C57BJ/L mice were
sacrificed by cervical dislocation. Under sterile conditions, midline
incision was made and abdominal skin was retraced gently with
forceps. 10 ml sterile PBS was injected slowly into the abdominal
cavity. Peritoneal fluids were withdrawn slowly. Approximately 6–
8 ml of fluid were recovered from each mouse. Lavage fluids from
several mice were pooled and cells were collected by centrifugation
at 400 g for 10 min. Cell were counted and cultured in DMEM
supplement with 10% FCS at a density of 6610
5 cells/ml. Primary
macrophage were allowed to attach overnight and fed with fresh
medium to culture for another day. Cells were starved in DMEM
supplemented with 1% FCS overnight and then incubated with
BMP4 or BMP6 and/or LPS in FCS-free DMEM supplemented
with 0.1% BSA as indicated. Cells were harvested and phospho-
Smad1/5/8 levels or hepcidin mRNA levels were measured. All
the procedures were performed in accordance with Animal
Experimentation Ethics Approval by Brigham and Women’s
Hospital Animal Experimentation Ethics Committee.
Transfection
To examine the effect of HJV overexpression on hepcidin
expression in RAW264.7 macrophages, cells were transfected with
Flag-HJV cDNA in 12-well plates using Lipofectamine 2000
(Invitrogen). Approximately 24 h after transfection, the media was
replaced with serum-free DMEM medium supplemented with
0.1% BSA. 16 h later, the cells were harvested for measurement of
hepcidin mRNA expression.
Measurement of Gene Expression
Real-time quantification of mRNA transcripts was performed
using an AB 7600 real-time system (Applied Biosystems). First-
strand cDNA was amplified with previously described mouse
hepcidin and Id1 primers (11), and detected using SYBRH Green
PCR Master Mix (Applied Biosystems) according to the manu-
facturer’s instructions. In parallel, Rpl19 (ribosomal protein-like
19) transcripts were amplified and detected in a similar manner to
serve as an internal control. Standard curves were generated from
accurately determined dilutions of plasmid cDNAs or purified
PCR fragments as templates. Results are expressed as a ratio of the
gene of interest to Rpl19.
Western blotting
RAW264.7 cells or peritoneal primary macrophages were lysed
in TBS (50 mM Tris-HCl, 150 mM NaCl, and 1% Triton X-100
[pH 7.4]) containing protease inhibitor mixture (Pierce) and
phosphatase inhibitor mixture (Pierce) for 30 min on ice. After
centrifugation for 10 min at 4uC, the supernatant was assayed for
protein concentration by colorimetric assay (BCA kit; Pierce). A
total of 20–40 mg of protein was separated by SDS-PAGE and
transferred to polyvinylidene difluoride membranes. Membranes
were probed with anti–phospho-Smad1/5/8 (1:1000) or anti–
phospho-NF-kB p65 (1:1000). Membranes were stripped in 0.2 M
glycine (pH 2.5) and 0.5% Tween 20 for 10 min, and reprobed
with anti-Smad1 (1:1000), anti-NF-kB p65 (1:1000) or anti-b-actin
(1:10,000) antibodies.
Data analysis
Results from real time PCR analyses are expressed as the means
6 S.D. of three replicates. Differences were assessed by Student’s t
test with P,0.05 used to indicate significance.
Results
BMP signaling does not stimulate hepcidin expression in
macrophages
It is well documented that BMPs stimulate hepcidin expression
in hepatocytes. To examine whether or not BMP signaling plays a
role in hepcidin expression in macrophages, we incubated
RAW264.7 macrophages with BMP4. Surprisingly, hepcidin
mRNA levels were not stimulated by BMP4 with concentrations
of up to 200 ng/ml (Fig. 1A), while expression of Id1 mRNA, a
well-known target gene of the BMP pathway, was increased by
BMP4 in a dose-dependent manner (Fig. 1B). A time course of 0 to
8 h for BMP4 treatment (50 ng/ml) also demonstrated no change
in hepcidin expression (Fig. 1C), despite an increase in Id1
expression and phosphorylated Smad1/5/8 levels 1 h after BMP4
treatment (Fig. 1D &1E). Similar results were seen with J774
macrophages (data not shown). In addition, BMP4 did not alter
hepcidin expression in primary peritoneal macrophages isolated
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left and right panels, Fig. 1F).
BMP6 appears to be a key endogenous BMP ligand for hepcidin
expression in the liver [11]; [15]. Therefore, we also examined
whether BMP6 could regulate hepcidin expression in macrophag-
es. BMP6 failed to stimulate hepcidin expression in RAW264.7
macrophages (Fig. 2A), while it dramatically increased Id1
expression (Fig. 2B) and stimulated phosphorylated Smad1/5/8
levels (Fig. 2C). Similarly, BMP6 did not have any effect on
hepcidin expression in primary peritoneal macrophages (Fig. 2D),
while it stimulated Smad1/5/8 phosphorylation (the right panel,
Fig. 1F). In addition, BMP6 did not affect hepcidin expression in
J774 macrophages either (data not shown).
HJV is a co-receptor for BMP signaling that increases BMP
signaling and hepcidin expression in hepatocytes. Our previous
study showed that expression of endogenous HJV in RAW264.7
cells is low [26]. Overexpression of HJV did not alter hepcidin
expression in RAW264.7 cells (Fig. 3A), although it was sufficient
to potentiate Id1 expression (Fig. 3B), suggesting that the lack of a
Figure 1. Effects of BMP4 on hepcidin expression in macrophages. (A, B, C and D) Effects of BMP4 on hepcidin and Id-1 expression in
RAW264.7 macrophages. Cells were incubated overnight with increasing amounts of BMP4 (A & B) or with 50 ng/ml of BMP4 for increasing periods of
time (C &D) in serum free DMEM supplemented with 0.1% BSA. Cells were collected for measurements of hepcidin (A & C), Id1 (B & D) and RPL19
mRNA levels. (E) Effects of BMP4 on phosphorylation levels of Smad1/5/8 in RAW264.7 macrophages. Cells were incubated with BMP4 for 1 h before
cells were lysed for Western blotting for phospho-Smad1/5/8 and Smad1 levels. (F) Left panel: Effects of BMP4 on hepcidin expression in primary
mouse peritoneal macrophages. Cells were incubated for 8 h with increasing amounts of BMP4 before cells were collected for quantification of
hepcidin and RPL19 mRNA levels. Right panel: Effects of BMP4 and BMP6 on phosphorylation levels of Smad1/5/8 in primary mouse peritoneal
macrophages. Cells were incubated with BMP4 or BMP6 for 1 h before cells were lysed for Western blotting for phospho-Smad1/5/8 and Smad1
levels. **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0044622.g001
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expression of this co-receptor in RAW264.7 cells.
These results suggest that, unlike hepatocytes, macrophages do
not respond to BMP stimulation with an increase in hepcidin
expression. This unresponsiveness cannot be attributed to defects
in BMP signaling in macrophages because Smad1/5/8 phosphor-
ylation and Id1 expression were induced by treatment with BMP4
or BMP6, and Id1 expression was induced by overexpression of
HJV.
BMP4 and BMP6 stimulate hepcidin expression in
macrophages in the presence of LPS
Hepcidin in macrophages is stimulated by bacterial pathogens
and LPS [18]. Consistent with these observations, LPS signifi-
cantly increased hepcidin expression in RAW264.7 cells in a time-
dependent manner (Fig. 4). To examine whether BMP can
influence hepcidin expression in macrophages activated by LPS,
we incubated RAW264.7 cells (Fig. 5A & B) or primary peritoneal
macrophages (Fig. 5C & D) with varying concentrations of BMP4
or BMP6 in the presence of LPS. In the presence of LPS co-
stimulation, BMP4 and BMP6 were able to stimulate hepcidin
expression in both the RAW264.7 macrophage cell line and
primary peritoneal macrophages. These results suggest that
additional intracellular signals are required for BMP regulation
of hepcidin expression in macrophages.
The stimulation of hepcidin expression by BMP signaling
in the presence of LPS is dependent on the NF-kB
pathway
A previous study showed that LPS-induced hepcidin expression
is mediated by the NF-kB signaling pathway in human leukocytes
[23]. To examine whether the NF-kB is also involved in hepcidin
expression induced by LPS and BMP4 in macrophages, we used
the NF-kB inhibitor Ro1069920 [27]. As shown in Fig. 6A and
6B, this inhibitor reduced phosphorylation levels of NF-kB p65
induced by LPS, but did not affect phosphorylation levels of
Smad1/5/8 induced by BMP4 in RAW264.7 macrophages. While
LPS stimulated hepcidin expression more than 3-fold above basal
levels (Fig. 6C, bar 2), the addition of BMP4 further increased
hepcidin mRNA levels (Fig. 6C, bar 3). Incubation with
Ro1069920 reduced hepcidin levels stimulated by LPS alone
(Fig. 6C, bar 4) or by BMP4 in combination with LPS (Fig. 6C,
bar 5) to basal levels. Similarly, BMP6 in combination of LPS
increased hepcidin expression over LPS alone (compare bars 2 and
3, Fig. 6D). In the presence of Ro1069920, hepcidin levels were
dramatically inhibited and they were no longer different between
cells treated with LPS alone and with BMP6 plus LPS (compare
bars 4 and 5, Fig. 6D). Taken together, these results suggest that
the potentiation of LPS-induced hepcidin expression by BMP
signaling in macrophages is dependent on NF-kB co-signaling.
Figure 2. Effects of BMP6 on hepcidin expression in RAW264.7 macrophages. (A and B) Cells were incubated for 8 h with increasing
amounts of BMP6 in serum free DMEM supplemented with 0.1% BSA. Cells were collected for real time RT-PCR analyses to qualify hepcidin (A), Id1 (B)
and RPL19 mRNA levels. (C) Effects of BMP6 on phosphorylation levels of Smad1/5/8 in RAW264.7 macrophages. Cells were incubated with BMP6 for
1 h before cells were lysed for Western blotting for phospho-Smad1/5/8 and Smad1 levels. (D) Effects of BMP6 on hepcidin expression in primary
mouse peritoneal macrophages. Cells were incubated for 8 h with increasing amounts of BMP6 before cells were collected for quantification of
hepcidin and RPL19 mRNA levels. ***, P,0.001.
doi:10.1371/journal.pone.0044622.g002
Regulation of Hepcidin by BMP in Macrophages
PLOS ONE | www.plosone.org 4 September 2012 | Volume 7 | Issue 9 | e44622Discussion
Hepcidin enhances the host immune defense by its antimicro-
bial and antifungal activities, and by its negative regulation of
serum iron levels. Hepcidin is mainly produced by the liver, but it
is also expressed in myeloid cells including macrophages and
monocytes. Infections stimulate hepcidin expression in both
hepatocytes and myeloid cells, leading to an increase in hepcidin
concentrations in circulation and in urine. Although the contri-
bution of myeloid cells to the circulating hepcidin relative to that
of hepatocytes during infections is difficult to determine, emerging
evidence suggests that hepcidin produced from macrophages and
monocytes under the stimulation of bacterial pathogens or LPS
inhibits the growth of bacteria while inducing iron retention in
these cells. Depletion of iron from monocytic lineage impairs LPS-
induced expression of inflammatory cytokines including interferon
b, whereas iron retention appears to potentiate these cytokine
responses [24]. Therefore, the paracrine/autocrine actions of
hepcidin may play an important role in the innate immunity
mediated by macrophages and monocytes.
A number of differences in the regulatory mechanisms of
hepcidin expression have been identified for myeloid cells and
hepatocytes. For example, hepcidin expression in macrophages in
the spleen is not regulated by serum iron levels, while hepatocytes
increase hepcidin expression in response to iron loading. In
leukocytes [23] and lymphocytes [28], TNF-a is potent in inducing
hepcidin expression. In hepatocytes, however, IL-6 and IL-1
stimulate hepcidin expression while TNF-a does not have such an
effect [4]; [6]; [29]; [30]; [31]. In the present study, we have
identified another difference between hepatocytes and macro-
phages, i.e. unlike hepatocytes, macrophages did not increase
hepcidin expression in response to BMP signaling under basal
conditions. In our experiments, the exposure of RAW264.7 or
J774 macrophages to two distinct BMP ligands (BMP4 and BMP6)
at varying doses and duration, the transfection of RAW264.7 with
HJV, a BMP co-receptor and potent hepcidin inducer in
hepatocytes, or the stimulation of primary peritoneal macrophages
with BMP4 and BMP6 all failed to induce hepcidin expression.
The mechanism underlying the failure of BMP signaling to
stimulate hepcidin expression in macrophages remains unknown.
Phosphorylation of Smad1/5/8 and Id1 expression was stimulated
by BMP4 or BMP6 in macrophages. This suggests that the BMP
signaling pathway is not defective. Whether there are any
transcription factors that are important for hepcidin transcription
but are not present or not activated in macrophages, and whether
there are any epigenetic differences in the hepcidin promoter
between hepatocypes and macrophages remain to be addressed. A
recent study showed that the binding motif of HNF4a, a liver
specific transcription factor, in the hepcidin promoter is critical for
the HJV and BMP response of hepcidin in hepatocytes [32].
However, we failed to rescue the BMP response of hepcidin
expression by forced expression of HNF4a in RAW264.7
macrophages (data not shown).
STAT3 is a key transcription factor involved in regulation of
hepcidin in hepatocytes in inflammatory conditions [30]; [31].
However, in neutrophils or leukocytes, inhibition of STAT3 did
not have any effect on LPS-induced hepcidin expression, while
inhibition of NF-kB activity abolished the stimulation of hepcidin
expression by LPS. Therefore, hepcidin expression induced by
LPS in neutrophils or leukocytes depends on the NF-kB pathway
[23]. In fact, there is a NF-kB binding site in the proximal region
of the mouse hepcidin promoter, and mutation of the NF-kB site
completely abolished hepcidin promoter activity in RAW264.7
Figure 3. Effects of HJV on hepcidin expression in RAW264.7
macrophages. Cells were tranfected with HJV cDNA (4 ng/ml).
48 hours after transfection, the cells were collected for real time RT-
PCR analyses to qualify hepcidin (A) and Id1 (B). *, P,0.05.
doi:10.1371/journal.pone.0044622.g003
Figure 4. Effects of LPS on hepcidin expression in RAW264.7
macrophages. Cells were incubated with LPS (10 ng/ml) in serum free
DMEM supplemented with 0.1% BSA, and were collected at the
indicated times for real time RT-PCR analyses to qualify hepcidin and
RPL19 mRNA levels. *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0044622.g004
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role of NF-kB for hepcidin promoter activity [22]. In the present
study, we found that, in the presence of LPS co-stimulation, BMP4
stimulated hepcidin expression in RAW264.7 and primary
peritoneal macrophages. Interestingly, the potentiation of LPS-
induced hepcidin by BMP4 or BMP6 was completely abrogated
by inhibition of NF-kB activity in RAW264.7 macrophages. These
results suggest that the action of LPS on hepcidin expression is also
dependent on NF-kB activity in macrophages, and that NF-kB
pathway plays a key role in determining the BMP response of
hepcidin expression in macrophages. A previous study showed that
inhibition of NF-kB signaling pathway completely blocked the
induction of iNOS expression by BMP6 in RAW264.7 cells [33].
These results suggest that the crosstalk between the NF-kB
Figure 5. Effects of BMP4 on hepcidin expression in macrophages in the presence of LPS. (A and B) RAW264.7 cells were incubated with
increasing amounts of BMP4 (A) or BMP6 (B) in the presence of LPS (10 ng/ml) for 8 h. Cells were collected for real time RT-PCR analyses to qualify
hepcidin and RPL19 mRNA levels. (C and D) Primary mouse peritoneal macrophages were incubated with BMP4 (C) or BMP6 (D) in the presence of
LPS (10 ng/ml) for 8 h. Cells were collected for real time RT-PCR analyses to qualify hepcidin and RPL19 mRNA levels. (B) *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0044622.g005
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phage functions.
The mechanisms responsible for the effects of BMPs on
hepcidin expression in the presence of LPS co-stimulation were
not examined in the present study. Previous studies have shown
that LPS induces SOCS3 expression, and SOCS3 inhibits
hepcidin expression as a negative feedback. Studies have also
shown that TGF-b1 inhibits SOCS3 expression [34]. It is
tempting to speculate that BMP signaling may also inhibit SOCS3
expression, thus potentiating LPS action in stimulating hepcidin
expression.
Augmented BMP signaling via the enhanced expression of BMP
ligands, Smad effectors or their downstream activation, has been
frequently observed to be a hallmark of infection, inflammation
and local tissue injury [35]; [36]; [37]; [38]. Just as it is possible
that the activation of pathogen associated molecular pattern
(PAMP) signaling pathways via molecules such as LPS might
adaptively recruit innate immune responses in synergy with tissue
damage signals marked by BMP ligand signaling, it is also possible
that the absence of BMP signals may limit inflammation when it is
inappropriate. We speculate further that this novel mechanism of
cooperative signaling between BMP and LPS in regulating
hepcidin in monocytic lineages might be exploited therapeutically
to enhance immunity or dampen inflammation via pharmacologic
BMP signaling modulation.
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